ARID1A and cancer: In multivariable meta-regression analyses, significant moderators emerged only for all-cause mortality, including differences in percentage of low-grade cancers between ARID1A− vs. ARID1A+ and studies about gastrointestinal and gynecological cancers compared to urological cancers (Supplementary Table 4).